Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Agilent Technologies to Distribute Proscia Digital Pathology Platform

By Author Proscia | March 8, 2023

Agilent Technologies announced on Wednesday that it has entered a multiyear distribution agreement with digital pathology firm Proscia to offer its Concentriq Dx* platform.

*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency. 

Our website uses cookies. By using this site, you agree to its use of cookies.